 |
 |
|
|
RESÚMENES ENERO 2007 |
Psychotic Disorders
& Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
Cognitive aspects
evaluation of schizophrenic men under haloperidol or clozapine
treatment
Rejane
Veiga Oliveira Johann e Cícero E. Vaz
J Bras Psiquiatr,
55(3): 202-207, 2006
TEXTO GRATUITO
Utilization of
Long-Acting Antipsychotic Medication in Patient Care
John M. Kane
CNS Spectr
11:12 (Suppl 14):1-8
TEXTO GRATUITO
Effects of treatment with the atypical neuroleptic
quetiapine on working memory function: a functional
MRI follow-up investigation
E.M. Meisenzahl,
J. Scheuerecker, M. Zipse,
S. Ufer, M. Wiesmann,
T. Frodl, N. Koutsouleris,
T. Zetzsche, G. Schmitt, M. Riedel,
I. Spellmann, S. Dehning,
J. Linn, H. Brückmann and H.J. Möller
European Archives of Psychiatry and Clinical
Neuroscience. December 21, 2006
Occupancy of dopamine D1, D2 and serotonin2A
receptors in schizophrenic patients treated with flupentixol
in comparison with risperidone and haloperidol
M. Reimold, C. Solbach, S. Noda, J.-E. Schaefer,
M. Bartels, M. Beneke, H.-J. Machulla, R. Bares, T. Glaser and H. Wormstall
Psychopharmacology. Volume 190, Number 2 / February, 2007: 241-249
Potential Clinical Targets of Repetitive Transcranial Magnetic Stimulation Treatment in
Schizophrenia
J. Cordes, M. Arends, A. Mobascher, J. Brinkmeyer, J. Kornischka, P. Eichhammer, A. Klimke, G. Winterer, M.W. Agelink
Neuropsychobiology 2006;54:87-99
Lower weight gain with the orally
disintegrating olanzapine than with standard tablets
in first-episode never treated psychotic patients
Arranz B, San L, Duenas RM, Centeno M, Ramirez N, Salavert J, Del Moral E
Hum Psychopharmacol. 2006
Dec 27;22(1):11-15
Late-onset
schizophrenia or chronic delusion
H. Convert,
C. Védie, P. Paulin
L’Encephale. Vol 32 - N° 6 - Décembre 2006 :
957 - 961
Benzodiazepines and
schizophrenia, a review of the literature
R. Gaillard, Ouanas,
Spadone, Llorca,
Lôo, Baylé
L’Encephale. Vol 32 - N° 6 - Décembre 2006: 1003 - 1010
Neurotensin Agonists: Potential in the
Treatment of Schizophrenia.
Boules,
Mona; Shaw, Amanda; Fredrickson, Paul; Richelson,
Elliott
Restarting Clozapine after Neutropenia:
Evaluating the Possibilities and Practicalities.
Whiskey,
Eromona; Taylor, David
Risk of diabetes mellitus associated with
atypical antipsychotic use among medicaid patients
with bipolar disorder: a nested case-control study
Guo JJ,
Pharmacotherapy. 2007 Jan;27(1):27-35
Menstrual Disturbance and Galactorrhea in People Taking Conventional Antipsychotic
Medications
Karthik Thangavelu and S. Geetanjali
Experimental and Clinical Psychopharmacology. Volume 14, Issue 4, November 2006, Pages 459-460
Elevated Prenatal Homocysteine
Levels as a Risk Factor for Schizophrenia
Alan S. Brown, Teodoro Bottiglieri, Catherine A. Schaefer, Charles P. Quesenberry, Jr, Liyan Liu, Michaeline Bresnahan, Ezra S. Susser
Arch Gen Psychiatry. 2007;64:31-39
Incidence of Hospitalization for Postpartum Psychotic
and Bipolar Episodes in Women With and Without Prior Prepregnancy
or Prenatal Psychiatric Hospitalizations
Bernard L. Harlow, Allison F. Vitonis,
Par Sparen, Sven Cnattingius,
Hadine Joffe, Christina M. Hultman
Arch Gen Psychiatry. 2007;64:42-48
Unique pharmacological profile of aripiprazole as the phasic
component buster
Hamamura T, Harada T
Psychopharmacology
(Berl). 2007 Jan 5; [Epub ahead of print]
Analysis of clinical symptomatology,
extrapyramidal symptoms and neurocognitive
dysfunction following dehydroepiandrosterone (DHEA)
administration in olanzapine treated schizophrenia
patients: A randomized, double-blind placebo controlled trial
Psychoneuroendocrinology. 2007 Jan 5; [Epub ahead of
print]
Blood Glucose in Chronic Schizophrenic
Patients Treated with Antipsychotics
Wetterling T, Schneider B, Weber B
Psychiatr Prax. 2006 Dec 7; [Epub ahead of print]
Initial Treatment of Severe
Acute Psychosis with Fast Orally Disintegrating Risperidone
Tablets
C. Normann, M. Schmauß, N. Bakri, M. Gerwe,
A. Schreiner
Pharmacopsychiatry 2006; 39: 209-212
Normal pituitary volumes in chronic
schizophrenia
Kalliopi Tournikioti, Michele Tansella, Cinzia Perlini, Gianluca Rambaldelli, Roberto Cerini, Amelia Versace, Nicola Andreone,
Nicola Dusi, Matteo Balestrieri, Roberto Malagò, Anna
Gasparini and Paolo Brambilla
Psychiatry Research: Neuroimaging.
Volume 154,
Issue 1, 15 January 2007, Pages 41-48
Glucose
and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia
MARI MURASHITA, TAKESHI INOUE, ICHIRO KUSUMI, SHIN NAKAGAWA, KOUICHI ITOH,
TERUAKI TANAKA, TAKESHI IZUMI, HIROSHI HOSODA, KENJI KANGAWA, TSUKASA KOYAMA
Psychiatry and Clinical Neurosciences 2007; 61 (1),
54–58
Perospirone
in the treatment of patients with delirium
TAKEUCHI, KO FURUTA, TOSHIYUKI HIRASAWA, HIDEKAZU MASAKI, TOMOAKI YUKIZANE,
HIDENORI ATSUTA, TORU NISHIKAWA
Psychiatry and Clinical
Neurosciences 2007; 61 (1), 67–70
Paliperidone Extended-Release Tablets
for Prevention of Symptom Recurrence in Patients With
Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Kramer,
Michelle; Simpson, George; Maciulis, Valentinas; Kushner, Stuart; Vijapurkar,
Ujjwala; Lim, Pilar; Eerdekens, Marielle
Journal of Clinical
Psychopharmacology. 27(1):6-14,
February 2007
Weight Gain During a Double-Blind Multidosage Clozapine Study
de
Leon, Jose; Diaz, Francisco J; Josiassen, Richard C;
Cooper, Thomas B; Simpson, George M
Journal
of Clinical Psychopharmacology. 27(1):22-27, February 2007
Second-Generation
Antipsychotic Exposure and Metabolic-Related Disorders in Patients With Schizophrenia: An Observational Pharmacoepidemiology
Study From 1988 to 2002
Reist,
Christopher; Mintz, Jim; Albers,
Journal of Clinical Psychopharmacology.
27(1):46-51, February 2007
A
double-blind, placebo-controlled trial of sibutramine
for clozapine-associated weight gain
D. C. Henderson, X. Fan, P. M. Copeland, C. P. Borba,
T. B. Daley, D. D. Nguyen, H. Zhang, D. Hayden, O. Freudenreich,
C. Cather, A. E. Evins, D. C. Goff
Acta Psychiatrica Scandinavica 2007; 115 (2), –.
The
A. Riecher-Rössler, U. Gschwandtner,
J. Aston, S. Borgwardt, M. Drewe,
P. Fuhr, M. Pflüger, W. Radü, Ch. Schindler, R.-D. Stieglitz
Acta Psychiatrica Scandinavica 2007; 115 (2), –.
EPS Profiles: The Atypical Antipsychotics: Are Not All the Same
Journal of Psychiatric Practice. 13(1):13-24,
January 2007
Clin Pharmacol Ther. 2007 Jan 18; [Epub ahead of
print]
Eur Neuropsychopharmacol.
2007 Jan 15; [Epub ahead of print]
Antipsychotics in the Treatment of Delirium: A Systematic Review
Dallas P.
Seitz, Sudeep S. Gill, and Louis T. van Zyl
J
Clin Psychiatry 2007;68:11-21
John W.
Goethe, Bonnie L. Szarek, Charles F. Caley, and Stephen B. Woolley
J
Clin Psychiatry 2007;68:22-28
J
Clin Psychiatry 2007;68:29-36
J
Clin Psychiatry 2007;68:75-80
Richard J.
Drake, Graham Dunn, Nick Tarrier, Richard P. Bentall, Gillian Haddock, and Shôn
W. Lewis
J
Clin Psychiatry 2007;68:81-86
J
Clin Psychiatry 2007;68:111-119
Three-year
antipsychotic effectiveness in the outpatient care of schizophrenia:
Observational versus randomized studies results
European Neuropsychopharmacology.
Volume 17, Issue 4, March
2007, Pages 235-244
Non-steroidal anti-inflammatory drugs and the risk of psychosis
W. Laan, Jean-Paul Selten, D.E. Grobbee, H. Smeets, René S. Kahn
and Huibert Burger
European Neuropsychopharmacology.
Volume 17, Issue 4, March
2007, Pages 309-311
Potkin SG, Gharabawi GM, Greenspan AJ, et al
Evidence-Based
Mental Health 2007;10:15
Review: aripiprazole
for schizophrenia—more high quality research required
El-Sayeh
HG, Morganti C, Adams CE
Evidence-Based
Mental Health 2007;10:14
Driving Ability in Schizophrenic
Patients - Stability and Course
Elisabeth
Geiger, Alexander Brunnauer, Gerd Laux
Sedative Antidepressants in the
Treatment of Primary Insomnia. An Evidence-Based Approach?
Kirsten Lange, Peter
Geisler, Helmfried E. Klein, Göran Hajak
Therapeutic Drug Monitoring of Risperidone: Relevance, Clinical Practice and
Interpretation
Markus Wittmann,
Wolfgang Bader, Helmut Hausner, Helmfried E. Klein, Ekkehard Haen
Psychiat Prax 2007;
34: 111-113
Neuroscience Letters. Volume 413, Issue 1, 8 February 2007,
Pages 82-87